US20150305749A1 - Removable anchored lung volume reduction devices and methods - Google Patents

Abstract

An intra-bronchial device may be placed and anchored in an air passageway of a patient to collapse a lung portion associated with the air passageway. The device includes an obstructing member that prevents air from being inhaled into the lung portion, and an anchor that anchors the obstruction device within the air passageway. The anchor may piercingly engage the air passageway wall. The anchor may be releasable from the air passageway for removal of the obstructing member. The anchor may be releasable by collapsing a portion of the obstructing member, or by drawing the obstructing member toward the larynx. The obstructing member may be a one-way valve.

Description

CROSS-REFERENCE TO RELATED APPLICATIONS
• This application is a continuation of U.S. patent application Ser. No. 13/853,345, titled REMOVABLE ANCHORED LUNG VOLUME REDUCTION DEVICES AND METHODS and filed Mar. 29, 2013, which is now pending. U.S. patent application Ser. No. 13/853,345 is a continuation of U.S. patent application Ser. No. 13/415,616, titled REMOVABLE ANCHORED LUNG VOLUME REDUCTION DEVICES AND METHODS and filed Mar. 8, 2012, now U.S. Pat. No. 8,603,127. U.S. patent application Ser. No. 13/415,616 is a continuation of U.S. patent application Ser. No. 13/198,546, titled REMOVABLE ANCHORED LUNG VOLUME REDUCTION DEVICES AND METHODS and filed Aug. 4, 2011, now U.S. Pat. No. 8,177,805. U.S. patent application Ser. No. 13/198,546 is a continuation of U.S. patent application Ser. No. 11/880,090, titled REMOVABLE ANCHORED LUNG VOLUME REDUCTION DEVICES AND METHODS and filed Jul. 19, 2007, now U.S. Pat. No. 8,021,385. U.S. patent application Ser. No. 11/880,090 is a continuation of U.S. patent application Ser. No. 10/103,487, titled REMOVABLE ANCHORED LUNG VOLUME REDUCTION DEVICES AND METHODS and filed Mar. 20, 2002, now abandoned. The foregoing applications are hereby incorporated by reference herein in their entirety. Any and all priority claims identified in the Application Data Sheet, or any correction thereto, are hereby incorporated by reference under 37 CFR 1.57.
BACKGROUND OF THE INVENTION
• 1. Field of the Invention
• The present invention is generally directed to a removable anchored device, system, and method for treating Chronic Obstructive Pulmonary Disease (COPD). The present invention is more particularly directed to providing an anchored intra-bronchial obstruction that may be removable.
• 2. Description of the Related Art
• COPD has become a major cause of morbidity and mortality in the United States over the last three decades. COPD is characterized by the presence of airflow obstruction due to chronic bronchitis or emphysema. The airflow obstruction in COPD is due largely to structural abnormalities in the smaller airways. Important causes are inflammation, fibrosis, goblet cell metaplasia, and smooth muscle hypertrophy in terminal bronchioles.
• The incidence, prevalence, and health-related costs of COPD are on the rise. Mortality due to COPD is also on the rise. In 1991, COPD was the fourth leading cause of death in the United States and had increased 33% since 1979. COPD affects the patient's whole life. It has three main symptoms: cough; breathlessness; and wheeze. At first, breathlessness may be noticed when running for a bus, digging in the garden, or walking uphill. Later, it may be noticed when simply walking in the kitchen. Over time, it may occur with less and less effort until it is present all of the time. COPD is a progressive disease and currently has no cure. Current treatments for COPD include the prevention of further respiratory damage, pharmacotherapy, and surgery. Each is discussed below.
• The prevention of further respiratory damage entails the adoption of a healthy lifestyle. Smoking cessation is believed to be the single most important therapeutic intervention. However, regular exercise and weight control are also important. Patients whose symptoms restrict their daily activities or who otherwise have an impaired quality of life may require a pulmonary rehabilitation program including ventilatory muscle training and breathing retraining. Long-term oxygen therapy may also become necessary.
• Pharmacotherapy may include bronchodilator therapy to open up the airways as much as possible or inhaled betaagonists. For those patients who respond poorly to the foregoing or who have persistent symptoms, ipratropium bromide may be indicated. Further, courses of steroids, such as corticosteroids, may be required. Lastly, antibiotics may be required to prevent infections and influenza and pneumococcal vaccines may be routinely administered. Unfortunately, there is no evidence that early, regular use of pharmacotherapy will alter the progression of COPD.
• About 40 years ago, it was first postulated that the tethering force that tends to keep the intrathoracic airways open was lost in emphysema and that by surgically removing the most affected parts of the lungs, the force could be partially restored. Although the surgery was deemed promising, the lung volume reduction surgery (LVRS) procedure was abandoned. LVRS was later revived. In the early 1990's, hundreds of patients underwent the procedure. However, the procedure has fallen out of favor when Medicare stopping reimbursing for LVRS. Unfortunately, data is relatively scarce and many factors conspire to make what data exists difficult to interpret. The procedure is currently under review in a controlled clinical trial. However, what data does exist tends to indicate that patients benefited from the procedure in terms of an increase in forced expiratory volume, a decrease in total lung capacity, and a significant improvement in lung function, dyspnea, and quality of life. Improvements in pulmonary function after LVRS have been attributed to at least four possible mechanisms. These include enhanced elastic recoil, correction of ventilation/perfusion mismatch, improved efficiency of respiratory muscaulature, and improved right ventricular filling.
• Lastly, lung transplantation is also an option. Today, COPD is the most common diagnosis for which lung transplantation is considered. Unfortunately, this consideration is given for only those with advanced COPD. Given the limited availability of donor organs, lung transplant is far from being available to all patients.
• There is a need for additional non-surgical options for permanently treating COPD without surgery. A promising new therapy includes non-surgical apparatus and procedures for lung volume reduction by permanently obstructing the air passageway that communicates with the portion of the lung to be collapsed. The therapy includes placing an obstruction in the air passageway that prevents inhaled air from flowing into the portion of the lung to be collapsed. Lung volume reduction with concomitant improved pulmonary function may be obtained without the need for surgery. The effectiveness of obstructions may be enhanced if it is anchored in place. The effectiveness may also be enhanced if the obstruction is removable. However, no readily available apparatus and method exists for anchoring the obstruction, and for removal if required.
• In view of the foregoing, there is a need in the art for a new and improved apparatus and method for permanently obstructing an air passageway that is anchored in place, and that may be removed if required. The present invention is directed to a device, system, and method that provide such an improved apparatus and method for treating COPD.
SUMMARY OF THE INVENTION
• The present invention provides an anchored intrabronchial device for placement in an air passageway of a patient to collapse a lung portion associated with the air passageway. The device includes an obstructing member that prevents air from being inhaled into the lung portion to collapse the lung portion, and an anchor that anchors the obstruction device within the air passageway when the anchor is deployed. The anchor may engage the air passageway wall, and may pierce into the air passageway wall. The obstructing member and the anchor may be simultaneously deployable. The anchor may be releasable from the air passageway for removal of the obstructing member. A portion of the intra-bronchial device may be collapsible. The anchor may be releasable from the air passageway for removal of the obstructing member by collapsing a portion of the obstructing member, or by drawing the obstructing member proximally. The anchor may include a resilient material for imparting a force against the air passageway to deform the air passageway to more positively anchor the obstructing member. The anchor may comprise material having memory of an original shape, and resiliency to return the material to that shape. The obstructing member may comprise material having memory of an original shape, and resiliency to return the material to that shape. The obstructing member may be a one-way valve.
• In another embodiment of the present invention, a method of reducing the size of a lung by collapsing a portion of the lung is provided. The method includes the step of providing an intra-bronchial device comprising an obstructing member which is so dimensioned when deployed in an air passageway communicating with the portion of the lung to be collapsed to preclude air from being inhaled, and an anchor that anchors the obstructing member when the anchor is deployed. The method further includes the steps of placing the obstructing member in the air passageway, and deploying the anchor. The anchor may be releasable for removal of the obstructing member. The obstructing member may form a one-way valve. A portion of the obstructing member may be collapsible.
• In a further embodiment of the present invention, a method of reducing the size of a lung by collapsing a portion of the lung with a removable device is provided. The method includes the step of providing an intra-bronchial device and an obstructing member that is so dimensioned when deployed in an air passageway communicating with the portion of the lung to be collapsed to preclude air from being inhaled, and an anchor that anchors the obstructing member when the anchor is deployed. The method includes the additional steps of placing the obstructing member in the air passageway, deploying an anchor, and removing the obstructing member. The anchor is releasable from the air passageway for removal of the intra-bronchial device, and the step of removing the obstructing member includes the further step of releasing the anchor. The obstructing member may form a one-way valve. At least a portion of the obstructing member may be collapsible, and the step of removing the obstructing member includes the further step of collapsing a portion of the obstructing member.
• In yet another embodiment of the present invention, an air passageway-obstructing device is provided. The obstructing device includes obstructing means for obstructing air flow within the air passageway, and anchoring means to anchor the air passageway obstructing device within the air passageway.
• In yet a further embodiment of the present invention, an air passageway-obstructing device is provided that includes obstructing means for obstructing air flow within the air passageway, and anchoring means to anchor the air passageway obstructing device within the air passageway, the anchoring means being releasable for removal of the obstructing means from the air passageway.
• These and various other features as well as advantages which characterize the present invention will be apparent from a reading of the following detailed description and a review of the associated drawings.
BRIEF DESCRIPTION OF THE DRAWINGS
• The features of the present invention which are believed to be novel are set forth with particularity in the appended claims. The invention, together with further objects and advantages thereof, may best be understood by making reference to the following description taken in conjunction with the accompanying drawings, in the several figures of which like referenced numerals identify like elements, and wherein:
• FIG. 1 is a simplified sectional view of a thorax illustrating a healthy respiratory system;
• FIG. 2 is a sectional view similar toFIG. 1, but illustrating a respiratory system suffering from COPD and the execution of a first step in treating the COPD condition by reducing the size of a lung portion in accordance with the present invention;
• FIG. 3 is perspective view, partially in section, and to an enlarged scale, illustrating an intermediate step in the treatment;
• FIG. 4 is a perspective view of a conduit that may10 be utilized in practicing the present invention;
• FIG. 5 is a perspective view of an intra-bronchial device, with anchors located proximally on peripheral portions of the support members, as the device would appear when fully deployed in an air passageway in accordance with the present invention;
• FIG. 6 is a partial section view of the device ofFIG. 5 showing additional details of the support structure;
• FIG. 7 is a perspective view of the intra-bronchial device ofFIG. 5 anchored in an air passageway;
• FIG. 8 illustrates an intra-bronchial device, with anchors carried distally on the central support structure, fully deployed in an air passageway in accordance with an alternative embodiment of the invention;
• FIG. 9 is a perspective view of an intra-bronchial device, with proximal anchors carried on the central support structure, in accordance with an alternative embodiment of the invention;
• FIG. 10 is a side view of an intra-bronchial device, with proximal anchors carried on the central support structure, in accordance with an alternative embodiment of the invention;
• FIG. 11 is an end view of an intra-bronchial device, with proximal anchors carried on the central support structure, in accordance with an alternative embodiment of the invention;
• FIG. 12 is a perspective view of an intra-bronchial device, with distal friction anchors carried on the central support structure, in accordance with an alternative embodiment of the invention;
• FIG. 13 is a side view of an intra-bronchial device, with distal friction anchors carried on the central support structure, in accordance with an alternative embodiment of the invention;
• FIG. 14 is an end view of an intra-bronchial device, with distal friction anchors carried on the central support structure, in accordance with an alternative embodiment of the invention;
• FIG. 15 is a perspective view an intra-bronchial device similar to that ofFIGS. 12-14 anchored in an air passageway;
• FIG. 16 is a perspective view illustrating an alternative embodiment of a removable intra-bronchial device with proximal anchors carried on a peripheral portion of a plurality of support structure members in accord with the present invention;
• FIG. 17 is a side view of the device ofFIG. 16;
• FIG. 18 is a perspective view of a device in its deployed state with anchors carried on an obstructing member, in accordance with an alternative embodiment of the invention;
• FIG. 19 is a partial longitudinal sectional view of the device ofFIG. 18 in a collapsed state and located into a lumen for placement in an air passageway;
• FIG. 20 is a perspective view of the device ofFIG. 18 in its deployed and anchored state in an air passageway, in accordance with the present invention;
• FIG. 21 is a side view of an initial step in removing the device ofFIG. 18 from an air passageway;
• FIG. 22 is a side view of an intermediate step in removing the device ofFIG. 18 from an air passageway;
• FIG. 23 is a side view of another intermediate step in removing the device ofFIG. 18 from an air passageway;
• FIG. 24 is a side view illustrating the collapse of the device ofFIG. 18 during its removal from an air passageway;
• FIG. 25 is a perspective view of a device in its deployed state with anchors carried on the obstructing member, in accordance with an alternative embodiment of the present invention;
• FIG. 26 illustrates the placement and securing of the obstructing member of the device ofFIG. 25 to a support member; and
• FIG. 27 is a perspective view of the intra-bronchial device ofFIG. 25 fully deployed and anchored in an air passageway, in accordance with the present invention.
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT
• In the following detailed description of exemplary embodiments of the invention, reference is made to the accompanying drawings that form a part hereof. The detailed description and the drawings illustrate how specific exemplary embodiments by which the invention may be practiced. These embodiments are described in sufficient detail to enable those skilled in the art to practice the invention. It is understood that other embodiments may be utilized, and other changes may be made, without departing from the spirit or scope of the present invention. The following detailed description is therefore not to be taken in a limiting sense, and the scope of the present invention is defined by the appended claims.
• Throughout the specification and claims, the following terms take the meanings explicitly associated herein unless the context clearly dictates otherwise. The meaning of “a”, “an”, and “the” include plural references. The meaning of “in” includes “in” and “on.” Referring to the drawings, like numbers indicate like parts throughout the views. Additionally, a reference to the singular includes a reference to the plural unless otherwise stated or inconsistent with the disclosure herein.
• Additionally, throughout the specification, claims, and drawings, the term “proximal” means nearest the trachea, and “distal” means nearest the bronchioles.
• Briefly stated, an aspect of the invention provides an anchored intra-bronchial device for placement in an air passageway of a patient to collapse a lung portion associated with the air passageway. A further aspect of the invention provides removability of the intra-bronchial device, either by releasing the anchors for removal of the entire device or by separating the obstructing member and removing it.
• FIG. 1 is a sectional view of a healthy respiratory system. Therespiratory system20 resides within thethorax22 that occupies a space defined by thechest wall24 and thediaphragm26.
• Therespiratory system20 includes thetrachea28, theleft mainstem bronchus30, theright mainstem bronchus32, thebronchial branches34,36,38,40, and42 andsub-branches44,46,48, and50. Therespiratory system20 further includesleft lung lobes52 and54 andright lung lobes56,58, and60. Each bronchial branch and sub-branch communicates with a respective different portion of a lung lobe, either the entire lung lobe or a portion thereof. As used herein, the term “air passageway” is meant to denote either a bronchi or bronchiole, and typically means a bronchial branch or sub-branch which communicates with a corresponding individual lung lobe or lung lobe portion to provide inhaled air thereto or conduct exhaled air therefrom.
• Characteristic of a healthy respiratory system is the arched or inwardlyarcuate diaphragm26. As the individual inhales, thediaphragm26 straightens to increase the volume of thethorax22. This causes a negative pressure within the thorax. The negative pressure within the thorax in turn causes the lung lobes to fill with air. When the individual exhales, the diaphragm returns to its original arched condition to decrease the volume of the thorax. The decreased volume of the thorax causes a positive pressure within the thorax which in turn causes exhalation of the lung lobes.
• In contrast to the healthy respiratory system ofFIG. 1,FIG. 2 illustrates a respiratory system suffering from COPD. Here it may be seen that thelung lobes52,54,56,58, and60 are enlarged and that thediaphragm26 is not arched but substantially straight. Hence, this individual is incapable of breathing normally by movingdiaphragm28. Instead, in order to create the negative pressure inthorax22 required for breathing, this individual must move the chest wall outwardly to increase the volume of the thorax. This results in inefficient breathing causing these individuals to breathe rapidly with shallow breaths.
• It has been found that theapex portions62 and66 of theupper lung lobes52 and56, respectively, are most affected by COPD. Hence, bronchial sub-branch obstructing devices are generally employed for treating the apex66 of the right,upper lung lobe56. However, as will be appreciated by those skilled in the art, the present invention may be applied to any lung portion without departing from the present invention. As will be further appreciated by those skilled the in art, the present invention may be used with any type of obstructing member to provide an anchored obstructing device, which may be removed. The inventions disclosed and claimed in U.S. Pat. Nos. 6,258,100 and 6,293,951, both of which are incorporated herein by reference, provide an improved therapy for treating COPD by obstructing an air passageway using an intra-bronchial valve or plug. The present invention may be used with the apparatus, system, and methods of these patents as will be briefly described in conjunction with the disclosure of the preferred embodiments of the present invention.
• The insertion of an obstructing member treats COPD by deriving the benefits of lung volume reduction surgery without the need of performing the surgery. The treatment contemplates permanent collapse of a lung portion. This leaves extra volume within the thorax for the diaphragm to assume its arched state for acting upon the remaining healthier lung tissue. As previously mentioned, this should result in improved pulmonary function due to enhanced elastic recoil, correction of ventilation/perfusion mismatch, improved efficiency of respiratory musculature, and improved right ventricle filling. The present invention supports the use of intra-bronchial plugs to treat COPD by anchoring the obstruction device in the air passageway. The present invention further supports the use of intra-bronchial plugs by providing for their removal if necessary. Use of anchors can allow the obstructing member to be relatively loosely fitted against the air passageway wall, which may provide increased mucociliary transport of mucus and debris out of the collapsed lung portion.
• FIG. 2 also illustrates a step in COPD treatment using an obstructing member. Treatment is initiated by feeding a conduit orcatheter70 down thetrachea28, into theright mainstem bronchus32, into thebronchial branch42 and into and terminating within the sub-branch50. The sub-branch50 is the air passageway that communicates with thelung portion66 to be treated, and is also referred to herein asair passageway50. Thecatheter70 is preferably formed of flexible material such as polyethylene. Also, thecatheter70 is preferably preformed with abend72 to assist the feeding of the catheter from theright mainstem bronchus32 into thebronchial branch42.
• FIG. 3 illustrates a further step in a method for placing an obstructingmember90 in a bronchial sub-branch using a catheter. The invention disclosed herein is not limited to use with the particular method illustrated herein.Catheter70 includes an optionalinflatable sealing member74 for use with a vacuum to collapselung portion66 prior to insertion of obstructingmember90. The obstructingmember90 may be formed of resilient or collapsible material to enable the obstructingmember90 to be fed through thecatheter70 in a collapsed state. The obstructingmember90 and its anchors (not shown) are collapsed and fed into thecatheter70. Thestylet92 is used to push the obstructingmember90 to theend77 of thecatheter70 for placing the obstructingmember90 within theair passageway50 adjacent to thelung portion66 to be permanently collapsed. Optional sealingmember74 is withdrawn after obstructingmember90 is inserted.
• A function of the intra-bronchial device disclosed and claimed in this specification, including the detailed description and the claims, is described in terms of collapsing a lung portion associated with an air passageway. In some lungs, a portion of a lung may receive air from collateral air passageways. Obstructing one of the collateral air passageways may reduce the volume of the lung portion associated with the air passageway, but not completely collapse the lung portion as that term may be generally understood. As used herein, the meaning of “collapse” includes both a complete collapse of a lung portion and a partial collapse of a lung portion.
• Once deployed, the obstructing member precludes inhaled air from entering the lung portion to be collapsed. In accordance with the present invention, it is preferable that the obstructing member takes the form of a one-way valve. In addition to precluding inhaled air from entering the lung portion, the member further allows air within the lung portion to be exhaled. This results in more rapid collapse of the lung portion. In addition, anchoring obstructing members that preclude both inhaled and exhaled airflow are contemplated as within the scope of the invention.
• FIG. 4 illustrates the obstructing device in place withinair passageway50. Obstructingmember90 has expanded upon placement in theair passageway50 to seal theair passageway50. This causes thelung portion66 to be maintained in a permanently collapsed state. The obstructingmember90 may be any shape suitable for accomplishing its purpose, and may be a solid material or a membrane.
• More specifically, the obstructingmember90 has anouter dimension91, and when expanded, enables a contact zone with the air passagewayinner dimension51. This seals the air passageway upon placement of the obstructingmember90 in theair passageway50 for maintaining thelung portion66 in the collapsed state.
• Alternatively, thelung portion66 may be collapsed using vacuum prior to placement of obstructingmember90, or sealing theair passageway50 with obstructingmember90 may collapse it. Over time, the air within thelung portion66 will be absorbed by the body and result in the collapse oflung portion66. Alternatively, obstructingmember90 may include the function of a one-way valve that allows air to escape fromlung portion66.Lung portion66 will then collapse, and the valve will prevent air from being inhaled.
• FIG. 5 is a perspective view of an intra-bronchial device, with anchors located proximally on peripheral portions of the support members, as the device would appear when fully deployed in an air passageway in accordance with the present invention.Intra-bronchial device100 includes asupport structure101, acentral support structure109;support members102,104,106, and108;anchors112,114,116, and118; anchor ends122,124,126, and128; and an obstructingmember110.
• Thesupport structure101 of intra-bronchial device includescentral support structure109, andsupport members102,104,106, and108. Thesupport members102,104,106, and108, carryanchors112,114,116, and118; and anchor ends122,124,126, and128, respectively.Central support structure109 is a tubular member, preferably hypodermic needle tubing.Support members102,104,106, and108, are coupled mechanically tocentral support structure109, such as by crimping, or by other methods such as adhesive or welding.Support members102,104,106, and108 are generally similar to each other. The support members are preferably formed of stainless steel, Nitinol, or other suitable material having a memory of its original shape, and resiliency to return the material to that shape.
• Anchors112,114,116, and118 are extensions ofsupport members102,104,106, and108. The anchors are formed by bending the support members to an angle that will result in a deployed anchor engaging the air passageway wall by piercing it approximately perpendicularly. In this preferred embodiment, the bend angle is approximately a right angle. Anchor ends122,124,126, and128 may be shaped to promote piercing the air passageway wall.
• Obstructingmember110 is carried on thesupport structure101, and includes a flexible membrane open in the proximal direction and which may be formed of silicone or polyurethane, for example. The obstructingmember110 is secured to thecentral support structure109, and may be additionally secured to the support members at itslarger diameter91. It may be secured by adhesive, or other manner known in the art. Obstructingmember110 may be loosely carried onsupport members102,104,106, and108, such that it expands on inhalation to form a seal against a wall of the air passageway, and contracts on exhalation to allow air and mucociliary transport from the collapsed lung. This provides a one-way valve function.
• FIG. 6 is a partial section view of the device ofFIG. 5 showing additional detail of the support structure. The linear cross-section view ofFIG. 6 exposes the arrangement ofsupport members106 and108 in their deployed configuration.
• The details ofsupport members102 and104 are omitted fromFIG. 6 for clarity, but are the same assupport members106 and108. The distal end of obstructingmember110 is carried oncentral support structure109.Support members106 and108 are shown emanating fromcentral support structure109, and arranged to loosely support to obstructingmember110 at itslarger diameter91. This allows obstructingmember110 to expand on inhalation and seal at thecontact zone129, and to partially contract on exhalation to allow exhalation of air and mucociliary transport.
• In an alternative embodiment,support members106 and108 do not actively support obstructingmember110, and the expansion and contraction of obstructingmember110 is governed by its elasticity.
• FIG. 7 is a perspective view of the intra-bronchial device ofFIG. 5 anchored in an air passageway.Intra-bronchial device100 is illustrated withanchors112 and116 piercing into theair passageway wall130 ofair passageway50. This anchors theintra-bronchial device100 in place.
• Intra-bronchial device100 is collapsible for insertion into an internal lumen of a catheter. At least thesupport members102,104,106, and108, and the obstructingmember110, may be collapsed.Intra-bronchial device100 is inserted into the catheter lumen, which is typically already placed in theair passageway50 as generally illustrated inFIG. 3. Using the stylet,intra-bronchial device100 is advanced down the catheter lumen into theair passageway50 to where the device is to be deployed. Once the point of deployment is reached,intra-bronchial device100 is expelled from the catheter and assumes its deployed shape as illustrated inFIG. 5. Upon deployment, obstructingmember110 expands to form acontact zone129 with thewall130 of theair passageway50 to prevent air from being inhaled into the lung portion to collapse the lung portion. Simultaneously upon deployment, the memory and resiliency of thesupport members102,104,106, and108 impart a force on the anchor ends122,124,126, and128, and urge theanchors112,114,116, and118 to engageair passageway wall130 by piercing. The anchors pierce into and become embedded in thewall130 of theair passageway50, preferably without projecting through thewall130. Stops may be incorporated into the anchors to limit piercing of thewall130.
• For example, the bend between the support member and the anchor may form a stop.
• The preclusion of air from being inhaled into the lung portion may be terminated by eliminating the obstructing effect ofintra-bronchial device100. The preclusion of air by the embodiment illustrated inFIGS. 5-7 may be eliminated by releasinganchors112,114,116, and118 from theair passageway wall130. The anchors may be released by inserting a catheter intoair passageway50 in proximity tointra-bronchial device100. A retractor device, such as biopsy forceps, capable of gripping a portion ofintra-bronchial device100 is inserted in the catheter. The forceps are used to engage a portion of thesupport structure101 ofintra-bronchial device100, and draw it toward the catheter. The drawing action releases anchors112,114,116, and118 fromair passageway wall130. Theintrabronchial device110 is then drawn into the catheter with the forceps, causing thesupport structure101 and obstructingmember110 to collapse. Thecollapsed device100 now fully enters the catheter lumen for removal from the patient. Alternatively, the obstructing effect may be eliminated by grabbing the obstructingmember110, releasing it from thesupport structure101, and removing obstructingmember110 from the patient.
• FIG. 8 illustrates an intra-bronchial device, with anchors carried distally on the central support structure, fully deployed in an air passageway in accordance with an alternative embodiment of the invention. Theanchors112,114,116, and118 ofintra-bronchial device140 are carried on portions ofsupport members102,104,106, and108 distal of thecentral support structure109. The support members are gathered together and carried by thecentral support structure109. Other than theanchors112,114,116, and118 being formed and carried on distal portions ofsupport members102,104,106, and108,intra-bronchial device140 is substantially similar in construction, operation, and removal as theintra-bronchial device100 ofFIG. 5.
• Whenintra-bronchial device140 is compressed for insertion into the catheter lumen for placement in the air passageway, the anchors,112,114,116, and118 are collapsed into a first configuration. In the first configuration, the anchor ends122,124,126, and128 are moved toward obstructingmember110, and anchors112,114,116, and118 thereby folded toward obstructingmember110. Whenintra-bronchial device100 is deployed from the catheter lumen, the memory and resiliency of thesupport members102,104,106, and108 impart a force that moves theanchors112,114,116, and118 into a second configuration to engageair passageway wall130. This is the deployed configuration illustrated inFIG. 8. For removal, drawingintra-bronchial device140 toward the catheter causes the anchor ends122,124,126, and128 to move away from obstructingmember110 to a third configuration.Anchors112,114,116, and118 are thereby folded away from obstructingmember110 and are released from engagement withair passageway wall130 for removal of theintra-bronchial device140. In an alternative embodiment, theanchors112,114,116, and118 may be formed on additional support members carried bycentral support structure109, instead of being formed from distal portions ofsupport members102,104,106, and108.
• FIGS. 9-11 illustrate an intra-bronchial device, with proximal anchors carried on the central support structure, in accordance with an alternative embodiment of the invention.
• FIG. 9 is a perspective view,FIG. 10 is a side view, andFIG. 11 is an end view of the device.Intra-bronchial device150 is generally similar in construction, operation, placement, and removal to theintra-bronchial device100 ofFIG. 5. Its structure has six support members and three anchors, with anchor stops.Anchors112,114, and116 includestops152,154, and156, respectively.Intra-bronchial device150 also includes ananchor base160, ananchor base aperture165,anchor base angle163, andadditional support members103 and105.
• Central support structure109 extends both proximal and distal of obstructingmember110, and carriesanchor base161 proximal of obstructingmember110, carriesanchors112,114, and116, and includesanchor base aperture165. The linear plane ofanchors112,114, and116 intersectanchor base161 atanchor base angle163.Anchor base angle163 is selected to optimize anchor deployment force and anchor release.Stops152,154, and156 include a flat area to limit the piercing of the air passageway wall by anchor ends122,124, and126. In alternative embodiments, the stops can be any configuration or shape known to those skilled in the art to limit the piercing.
• In operation, whenintra-bronchial device150 is compressed for insertion into the catheter lumen for placement in the air passageway, anchors112,114, and116 are collapsed into a first configuration. In the first configuration, the anchor ends122,124, and126 are moved toward obstructingmember110, thereby decreasinganchor base angle163 and folding anchors112,114, and116 toward obstructingmember110. The anchor ends and the anchors may be moved by sliding a catheter or hollow member overanchor base161 and toward obstructingmember110. Whenintra-bronchial device150 is deployed from the catheter lumen, the memory and resiliency of theanchors112,114, and116,anchor angle163, andanchor base161 impart a force that moves the anchor members into a second configuration, which is the deployed configuration, to engageair passageway wall130. The second or deployed configuration is illustrated inFIGS. 9-11.Stops152,154, and156 limit the piercing of the air passageway wall by anchor ends122,124, and126.
• For removal, a retractor device is deployed from a catheter to engageanchor base161 and restrainintra-bronchial device150. The retractor device may be a biopsy forceps to engageanchor base161, or a hooked device to engageanchor base aperture165. A catheter is then moved distally overanchor base161, and in contact withanchors112,114, and116. The catheter is further moved againstanchors112,114, and116, whileintra-bronchial device150 is restrained atanchor base161. This releases theanchors112,114, and116 from the air passageway wall. This collapses the anchors into to the first configuration for removal.Intra-bronchial device150 is then further drawn into the catheter by pulling on the retractor device used to engageanchor base161. This collapsessupport structure101 and obstructingmember110 so that they may be fully drawn into the catheter. Once drawn into the catheter,intra-bronchial device160 may be removed from the air passageway and the patient.
• FIGS. 12-14 illustrate an intra-bronchial device, with distal friction anchors carried on the central support structure, in accordance with an alternative embodiment of the invention.
• FIG. 12 is a perspective view,FIG. 13 is a side view, andFIG. 14 is an end view.Intra-bronchial device160 is generally similar in construction, placement, and operation to theintra-bronchial device150 ofFIGS. 9-11.Intra-bronchial device160 is removed in the manner described in conjunction withFIG. 7. However,Intra-bronchial device160 differs fromintra-bronchial device150 in that the structure includes four distal anchors with anchor ends122,124,126, and128 shaped into pads that deform and frictionally engage the air passageway wall to more positively anchorintra-bronchial device160 without piercing. The structure also includes an obstructingmember support base170.
• Central support structure109 extends distal of obstructingmember110, and carriesanchor base161 distal of obstructingmember110.Anchor base161 carriesanchors112,114,116, and118. The linear plane ofanchors112,114,116, and118 intersectsanchor base161 atanchor angle163.Anchor angle163 is selected to optimize anchor deployment force and anchor release. Theanchors112,114,116, and118, andanchor base161 may be constructed by laser cutting a single piece of hypodermic tubing lengthwise to form theanchors112,114,116, and118, and then bending the anchors to formanchor angle163.Anchor base161 is secured tocentral support structure109.Support members102,103,104,105,106, and108, and the obstructing membersupport member base170 may be constructed in a like manner. Obstructingmember110 is secured to the obstructingmember support base170, and alternatively to supportmembers102,103,104,105,106, and108. The assembly of obstructingmember110 andsupport base170 is secured tocentral support structure109.Central support structure109 may extend proximal ofsupport member base170 to provide a surface for gripping theintra-bronchial device160 for removal, and may include an aperture to be engaged by a hooked device.
• FIG. 15 is a perspective view an intra-bronchial device similar to that ofFIGS. 12-14 anchored in an air passageway. It illustrates pad-shaped anchor ends122-128 ofintra-bronchial device180 deforming and frictionally engagingair passageway wall130.
• FIGS. 16 and 17 illustrate a removable intra-bronchial device with proximal anchors carried on a peripheral portion of a plurality of support structure members in accord with the present invention.FIG. 16 is a perspective view, as the device would appear when fully deployed in an air passageway.FIG. 17 is a side view ofFIG. 16. In a preferred embodiment, thesupport structure101 ofintra-bronchial device190 includes six support members, with two opposing pairs of support members carrying anchors and each member of a pair being joined together by a retracting member.Intra-bronchial device190 includes asupport structure101 having acentral support structure109 andsupport members102,103,104,105,106, and108; fouranchors113,114,116, and118 having anchor ends123,124,126, and128, respectively; two “U” shaped retractingmembers192 and194 having an apex193 and195, respectively; and obstructingmember110. As shown inFIG. 17, the support members extend in a curvilinear manner from the attachment at thecentral support structure109 such that an umbrella or substantially parabolic shape is defined. In addition, as also shown inFIG. 17, the free ends of thesupport members102,103,104,105,106,108 are bent radially inwards. In other words, the illustratedsupport members102,104,105,106,108 comprise tips at their free ends that are angled radially inwards.
• Intra-bronchial device190 is generally similar in construction, operation, placement, and removal to theintra-bronchial device150 ofFIG. 9.Support structure101 is a tubular member, preferably hypodermic needle tubing, or stainless steel, Nitinol, or other suitable material having a memory of its original shape and resiliency to return the material to that shape.Support members102,103,104,105,106, and108, andcentral support structure109 may be formed by laser cutting a single piece of hypodermic needle tubing lengthwise, and bending the support members to a required shape.Support members102,103,104,105,106, and108 are generally similar to each other.Anchors113,114,116, and118 are disposed onsupport members103,104,106, and108, respectively, in any manner available in the art. Anchors113-118 are disposed onsupport members103,104,106, and108 to be located proximally of obstructingmember110, and to engage an air passageway wall whenintra-bronchial device190 is deployed.
• “U” shaped retractingmember192 is coupled to supportmembers103 and104, and “U” shaped retractingmember194 is coupled to supportmembers106 and108. “U” shaped retractingmembers192 and194 may be constructed of any material suitable for use within a patient, and may or may not be resilient as required by the particular embodiment. Whenintra-bronchial device190 is fully deployed in an air passageway, the “U” shaped retractingmembers192 and194 are arranged opposite each other, and they partially overlap, with the apex of one lying within a space bounded by the “U” shape of the other member. In the deployed configuration, increasing the distance betweenapex193 and apex195 moves support member pairs103-104 and106-108 centrally.
• In operation, whenintra-bronchial device190 is compressed for insertion into a catheter lumen and placement in an air passageway,support members102,103,104,105,106, and108 are collapsed centrally into a first configuration. This causes the anchor ends123-124, and126-128 to move centrally.
• Whenintra-bronchial device190 is deployed from the catheter lumen, the memory and resiliency of the support member pairs103,104 and106,108 impart a force that moves theanchors113 and114, and116 and118, and their anchor ends123 and124, and126 and128 into a second configuration, which is the deployed configuration to engage air passageway wall. In addition, deployment ofintra-bronchial device190 may include a step of forcibly decreasing the distance betweenapexes193 and195 to forcibly move theanchors113 and114, and116 and118 into engagement with the wall of the air passageway. While theanchors113 and114, and116 and118 of this embodiment do not include stops, the expansive or peripheral movement of the anchors will be limited by obstructingmember90. This may limit the piercing of the air passageway wall byanchors113 and114, and116 and118.
• In an alternative embodiment, support member pairs103,104 and106,108 may be compressed for insertion into a catheter lumen by a device that increases the distance betweenapex193 andapex195. Such a device could be a tool with spreading jaws, or a tapered member inserted between the apexes. The device could be left in engagement after insertion into the catheter, and then withdrawn to allow support member pairs103-104 and106-108 to move apart and engage their anchors into the wall of the air passageway.
• For removal, a retractor device is deployed from a catheter lumen to engage apex193 and195, and restrainintra-bronchial device190. The retractor device may be any device that fits into the space defined byapexes193 and195 when theintra-bronchial device190 is in its fully deployed configuration. The retractor device is used to increase the distance betweenapexes193 and195 until anchors113-114 and116-118, and anchor ends123-124 and126-128 are released from the air passageway wall. This collapses the anchors into to the first configuration for removal.Intra-bronchial device190 is then further collapsed, and drawn into the catheter by pulling on the retractor device. This additionally collapsessupport structure101 and obstructingmember110 into the first position so that they may be fully drawn into the catheter. Once drawn into the catheter,intra-bronchial device190 may be removed from the air passageway and the patient.
• FIG. 18 is a perspective view of anintra-bronchial device200 with anchors carried on an obstructing member as the device would appear when fully deployed in an air passageway, in accordance with an alternative embodiment of the invention.Intra-bronchial device200 includes an obstructingmember90, anchors111,112,113,114,115,116,117, and118 (hereafter collectively referred to as anchors111-118), and anchor ends121,122,123,124,125,126,127, and128 (hereafter collectively referred to as anchor ends121-128).
• Obstructingmember90 may be a single piece made from a collapsible, resilient material, such as silicone, polyurethane, rubber, or foam, and typically will be collapsible to at least one-half of its expanded size. In an alternative embodiment, obstructingmember90 may include multiple pieces, some being of collapsible material. In a further alternative embodiment, obstructingmember90 may include a membrane carried by a support structure such as described in conjunction withFIGS. 5-17.
• Anchors111-118 comprise material having memory of an original shape, and resiliency to return the material to that hape, and typically have a diameter small enough that penetration through an air passageway wall may not adversely effect a patient. Anchors111-118 may be 0.003-inch diameter 316 stainless steel with a wire spring temper, Nitinol, or other resilient material. Anchor ends121-128 may be shaped to promote or control piercing of the air passageway wall. In an alternative embodiment, the length of the anchors111-118 may be limited to allow the anchors111-118 to penetrate into but not through the air passageway wall. In the preferred embodiment illustrated inFIG. 18, the anchors include four pieces of material pushed through obstructingmember90. The four pieces would lie in approximately the same cross-sectional plane, and cross each other at approximately the centerline of obstructingmember90, with approximately equal portions of the anchor material projecting from opposite sides of the obstructingmember90. In this embodiment, for example, anchors112 and116 would be opposite portions of a single piece of material. Anchors111-118 may be secured to control their position. For example, a centerline opening may be made in obstructingmember90 exposing the several pieces of anchoring material. The several pieces of material could them be joined together, or to obstructingmember90, at a location within the centerline opening by an adhesive, crimping, welding, or other method of mechanically joining materials known to those in the art.
• In an alternative embodiment, the anchors may be formed by individual pieces of material. The individual pieces of material may be coupled to obstructingmember90 either at its periphery, or within its periphery.
• FIG. 19 is a partial longitudinal sectional view of the intra-bronchial device ofFIG. 18 collapsed and located into a delivery catheter lumen for placement in an air passageway to collapse a lung portion associated with the air passageway, in accordance with the present invention.Intra-bronchial device200 is generally placed in an air passageway as described inFIGS. 2 and 3.
• More specifically,intra-bronchial device200 is collapsed and placed intodelivery catheter lumen70. Obstructingmember90 is collapsed into approximately a cylindrical shape. Anchors111-118 are collapsed to a position in proximity to or against the outer periphery of collapsed obstructingmember90.Intra-bronchial device200 is inserted intocatheter lumen70, the distal end of which is typically already placed in theair passageway50 as generally illustrated inFIG. 3. Usingstylet92,intra-bronchial device200 is advanced through thecatheter lumen70 into the air passageway to where it is to be deployed. Once the point of deployment is reached,intra-bronchial device200 is expelled fromcatheter lumen70, and assumes a deployed shape as illustrated inFIG. 18.
• FIG. 20 is a perspective view of the intra-bronchial device ofFIG. 18 in its fully deployed and anchored state in an air passageway, in accordance with the present invention.Intra-bronchial device200 is illustrated after having been expelled from the catheter lumen in substantially the manner described in conjunction withFIG. 3, and having deployedanchors112 and116 by piercing into and throughair passageway wall130 ofair passageway50. The piercing engages the air passageway wall and anchorsintra-bronchial device200 within theair passageway50.
• The resiliency of obstructingmember90 imparts a force to expand the obstructingmember90 from the collapsed state to a deployed state. In its deployed state, obstructingmember90 forms acontact zone129 with thewall130 ofair passageway50 preventing air from being inhaled into the lung portion. The resiliency of the anchor members111-118 moves them from their collapsed state illustrated inFIG. 19 to their deployed state. The resiliency of obstructingmember90 may assist anchor members111-118 in deployment. In the alternative embodiment where the length of anchors111-118 is limited to allow the anchors111-118 to penetrate into but not through the air passageway wall, the anchors penetrate theair passageway wall150 in the manner illustrated inFIG. 7.
• FIGS. 21-24 are side views showing an embodiment of the present invention for removing theintra-bronchial device200 fromair passageway50. The preclusion of air from being inhaled into the lung portion may be terminated by eliminating the obstructing effect ofintra-bronchial device200. The preclusion of air by the embodiment illustrated inFIG. 18 may be eliminated by releasing anchors111-118 from theair passageway wall130.
• Abronchoscope74 is placed in proximity tointrabronchial device200 in theair passageway50. Acatheter70 having aninternal lumen71 is fed into thebronchoscope74 and advanced to the proximal end of theintra-bronchial device200. A retractor device, such asbiopsy forceps76, capable of gripping a portion ofintra-bronchial device200, is inserted in thecatheter70 of thebronchoscope74 and advanced to theintra-bronchial device200. The jaws of theforceps76 are used to engage a portion of the obstructingmember90. The engagement may collapse a portion of obstructingmember90. The engagement with the obstructingmember90 is maintained and obstructingmember90 is drawn toward thecatheter lumen71 by theforceps76. The drawing action releases anchors111-118 fromair passageway wall130. Theintra-bronchial device200 is then drawn into thecatheter lumen71 with theforceps76. Thecollapsed device200 now fully enters thecatheter lumen71 for removal from the patient.
• FIG. 25 is a perspective view of an intra-bronchial device with anchors projecting from a periphery of an obstructing member as the device would appear when fully deployed, in accordance with an alternative embodiment of the present invention. Theintra-bronchial device210 includessupport members102,104,106, and108; an obstructingmember110; “s” shaped bends212,214,216, and218; and anchors112,114,116, and118.
• Thesupport members102,104,106, and108 form a support structure carrying obstructingmember110, and includeanchors112,114,116, and118; and anchor ends122,124,126, and128, respectively. Thesupport members102,104,106, and108 may be tubular members, and are preferably hypodermic needle tubing.Support members102,104,106, and108 form a support structure by being joined together at a location toward the distal portion ofintra-bronchial device210. They may be joined by a mechanical method, such as by crimping, or by other methods such as adhesive or welding. In an alternative embodiment, two support members may be formed from a single piece of material by bending it in the middle.Support members102,104,106, and108 are generally similar to each other. The support members are preferably formed of stainless steel, Nitinol, or other suitable material having a memory of its original shape, and resiliency to return the material to that shape.
• Anchors112,114,116, and118 are extensions ofsupport members102,104,106, and108. The anchors are formed by forming “s” shaped bends212,214,216, and218 in proximal portions of the support members. Anchor ends122,124,126, and128 may be shaped to promote piercing the air passageway wall.
• The obstructingmember110 is carried on the support structure formed bysupport members102,104,106, and108. Obstructingmember110 includes a flexible membrane open in the proximal direction and which may be formed of silicone or polyurethane, for example. The obstructingmember110 includesopenings222,224,226, and228 sized to sealingly admit the “s” shaped bends212,214,216, and218 ofsupport members102,104,106, and108, respectively.FIG. 26 illustrates the placement and securing of the obstructingmember110 to supportmember102 at “s”bend212.
• Obstructingmember110 is fitted over theanchor end122 andanchor112 atopening222. Obstructingmember110 engages the peripheral apex of the “s” shapedbend212, and thus secures it. The obstructingmember110 is placed and secured to the other “s” bends214,216, and218 in a similar manner.
• Obstructingmember110 may be loosely carried onsupport members102,104,106, and108 such that it expands on inhalation to form a seal against a wall of the air passageway, and contracts on exhalation to allow air and mucociliary transport from the collapsed lung. This provides a one-way valve function.
• FIG. 27 is a perspective view of the intra-bronchial device ofFIG. 25 fully deployed and anchored in an air passageway, in accordance with the present invention.Intrabronchial device210 is illustrated after having been expelled from the catheter lumen in substantially the manner described in conjunction withFIG. 3, and having deployedanchors112,114,116, and118 by piercing intoair passageway wall130 ofair passageway50. The piercing engages the air passageway wall and anchorsintra-bronchial device210 within theair passageway50.
• Deploying obstructingmember210 is much like opening an umbrella. Upon deployment, the memory and resiliency of thesupport members102,104,106, and108, expand obstructingmember210. The expanded obstructingmember210 forms acontact zone129 with thewall130 of theair passageway50 to prevent air from being inhaled into the lung portion to collapse the lung portion. Simultaneously upon deployment, the memory and resiliency of thesupport members102,104,106, and108 impart a force on the anchor ends122,124,126, and128, and urge theanchors112,114,116, and118 to engageair passageway wall130 by piercing. The anchors pierce into and become embedded in thewall130 of theair passageway50, preferably without projecting through thewall130. Stops may be incorporated into the anchors to limit piercing of thewall130. For example, the “s” bends212,214,216, and218 may form a stop.
• The preclusion of air from being inhaled into the lung portion may be terminated by eliminating the obstructing effect ofintra-bronchial device210. The preclusion of air by the embodiment illustrated inFIGS. 25-27 may be eliminated by releasinganchors112,114,116, and118 from theair passageway wall130. The anchors are released and theintra-bronchial device210 is removed fromair passageway50 in substantially the same manner described in conjunction withFIGS. 7, and21-24. The forceps are used to engage a portion ofintra-bronchial device210, and maneuvered to releaseanchors112,114,116, and118 from theair passageway wall130.Intra-bronchial device210 is then drawn into the catheter for removal from the patient. Alternatively, the obstructing effect may be eliminated by engaging the obstructingmember210, releasing it from thesupport members102,104,106, and108, and drawing obstructingmember110 into the catheter for removal from the patent.
• Although the present invention has been described in considerable detail with reference to certain preferred embodiments, other embodiments are possible. Therefore, the spirit or scope of the appended claims should not be limited to the description of the embodiments contained herein. It is intended that the invention resides in the claims hereinafter appended.

Claims (8)

1. (canceled)

2. An air passageway device, the device comprising:

an obstructing member having:

a closed distal end;

an opened proximal end; and

an axis extending between the closed distal end and the opened proximal end, the obstructing member configured to inhibit air flow in a distal direction past the air passageway device when the air passageway device is implanted in a target air passageway; and

a plurality of anchors connected to the distal end of the obstructing member, each of the plurality of anchors having:

a distal end; and

a proximal end positioned closer to the axis of the obstructing member than the distal end.

3. The air passageway device ofclaim 2, wherein the obstructing member is configured to exert a force upon a wall of the target airway passageway when the air passageway device is implanted in the target passageway.

4. The air passageway device ofclaim 3, wherein the obstructing member has an opened configuration and a closed configuration, and wherein the opened proximal end of the obstructing member has a perimeter larger than a perimeter of the target air passageway.

5. The air passageway device ofclaim 2, wherein the proximal end of each of the plurality of anchors is spaced from and distal of the closed distal end of the obstructing member.

6. The air passageway device ofclaim 2, comprising five anchors.

7. The air passageway device ofclaim 2, wherein the plurality of anchors are integrally formed with at least a portion of the obstructing member.

8. The air passageway device ofclaim 2, wherein the distal ends of the plurality of anchors are configured to exert a force upon a wall of the target air passageway when the air passageway device is implanted in the target air passageway.

Images